VEGFA and hepatocellular carcinoma: The recommended first-line systemic therapy regimens for HCC include a vascular endothelial growth factor (VEGF)-targeted agent plus an immune checkpoint inhibitor (ICI) or multiple tyrosine kinase inhibitors (mTKIs) alone.